Author Affiliations: Department of Pediatrics, First Affiliated Hospital, Guangxi Medical University, Nanning, 530021 Guangxi, China (Chen XQ, Wang LL, Shan QW, Tang Q, Deng YN, Lian SJ, Yun X)

Corresponding Author: Lin-Lin Wang, Department of Pediatrics, First Affiliated Hospital, Guangxi Medical University, Nanning, 530021 Guangxi, China (Tel: +86-771-5356505; Fax: +86-771-5356781; Email: WLL276@yahoo.com.cn)

doi: 10.1007/s12519-011-0299-z

Background: This study aimed to evaluate the genetic effect of the NR1H4 gene in the pathogenesis of idiopathic infantile cholestasis of Chinese subjects in Guangxi, China.

Methods: Seventy-eight patients with idiopathic infantile cholestasis served as a study group and 95 infants without cholestasis as controls. Genomic DNA was extracted from peripheral venous blood leucocytes by phenol chloroform procedures. Polymerase chain reaction (PCR) was used to amplify all coded exons of NR1H4, and single-strand conformation polymorphism (SSCP) was used to analyze all amplification fragments. The PCR products with abnormal bands in SSCP were sequenced using an ABI 3100 sequencer.

Results: A novel heterozygous termination codon mutation in NR1H4 exon 5 (NR1H4 R176X, CGA-TGA) was found in one of the 78 patients. The patient with mutation R176X had high levels of bilirubin, alanine aminotransferase, γ-glutamyltransferase, cirrhosis and ascites despite biliary tract flushing procedures and drug therapy. In the other patients and controls, no mutation was detected.

Conclusions: Heterozygous termination codon mutation of NR1H4 R176X was found in idiopathic infantile cholestasis. The novel mutation is useful to establish particular characteristics for differential diagnosis of idiopathic infantile cholestasis and to determine the influence of such gene defects in the prognosis.

Key words: cholestasis; farnesoid X receptor; infant; mutation; NR1H4

                    World J Pediatr 2012;8(1):67-71